BR112015024825A2 - polímero com base em glicogênio, complexo, composições farmacêutica, nutracêutica e cosmética, e, usos dos polímeros com base em glicogênio e de um complexo - Google Patents
polímero com base em glicogênio, complexo, composições farmacêutica, nutracêutica e cosmética, e, usos dos polímeros com base em glicogênio e de um complexoInfo
- Publication number
- BR112015024825A2 BR112015024825A2 BR112015024825A BR112015024825A BR112015024825A2 BR 112015024825 A2 BR112015024825 A2 BR 112015024825A2 BR 112015024825 A BR112015024825 A BR 112015024825A BR 112015024825 A BR112015024825 A BR 112015024825A BR 112015024825 A2 BR112015024825 A2 BR 112015024825A2
- Authority
- BR
- Brazil
- Prior art keywords
- glycogen
- complex
- nutraceutical
- pharmaceutical
- cosmetic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Jellies, Jams, And Syrups (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
1 / 1 resumo âpolãmero com base em glicogãnio, complexo, composiãães farmacãutica, nutracãutica e cosmãtica, e, usos dos polãmeros com base em glicogãnio e de um complexoâ a presente invenã§ã£o se refere aos polãmeros com base em glicogãªnio e ao uso do mesmo para intensificar a solubilidade em ã¡gua de compostos lipofãlicos, aos complexos dos ditos polãmeros com base em glicogãªnio com compostos lipofãlicos e ao uso do mesmo para administrar compostos lipofãlicos, e ã s composiã§ãµes farmacãªuticas, nutracãªuticas e cosmã©ticas que compreendem os ditos complexos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13162453 | 2013-04-05 | ||
PCT/EP2014/056451 WO2014161815A1 (en) | 2013-04-05 | 2014-03-31 | Glycogen-based water solubility enhancers |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015024825A2 true BR112015024825A2 (pt) | 2017-07-18 |
Family
ID=48049850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015024825A BR112015024825A2 (pt) | 2013-04-05 | 2014-03-31 | polímero com base em glicogênio, complexo, composições farmacêutica, nutracêutica e cosmética, e, usos dos polímeros com base em glicogênio e de um complexo |
Country Status (27)
Country | Link |
---|---|
US (1) | US10662259B2 (pt) |
EP (1) | EP2981557B1 (pt) |
JP (1) | JP6312801B2 (pt) |
KR (1) | KR102113707B1 (pt) |
CN (1) | CN105143274B (pt) |
AR (1) | AR095937A1 (pt) |
AU (1) | AU2014247145B2 (pt) |
BR (1) | BR112015024825A2 (pt) |
CA (1) | CA2905273A1 (pt) |
CY (1) | CY1122935T1 (pt) |
DK (1) | DK2981557T3 (pt) |
EA (1) | EA032500B1 (pt) |
ES (1) | ES2786900T3 (pt) |
GE (1) | GEP201706742B (pt) |
HK (1) | HK1215955A1 (pt) |
HR (1) | HRP20200693T1 (pt) |
HU (1) | HUE049561T2 (pt) |
IL (1) | IL241690B (pt) |
LT (1) | LT2981557T (pt) |
MX (1) | MX369778B (pt) |
PL (1) | PL2981557T3 (pt) |
PT (1) | PT2981557T (pt) |
RS (1) | RS60506B1 (pt) |
SG (2) | SG10201708099YA (pt) |
SI (1) | SI2981557T1 (pt) |
UA (1) | UA119441C2 (pt) |
WO (1) | WO2014161815A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014172786A1 (en) | 2013-04-26 | 2014-10-30 | Mirexus Biotechnologies Inc | Phytoglycogen nanoparticles and methods of manufacture thereof |
US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
JP6750740B2 (ja) * | 2018-03-30 | 2020-09-02 | ソニー株式会社 | 磁気記録媒体 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1514720A (en) * | 1974-10-07 | 1978-06-21 | Secr Defence | Preparation of hydroxyethyl starch |
US4228277A (en) * | 1979-02-12 | 1980-10-14 | Hercules Incorporated | Modified nonionic cellulose ethers |
IT1255488B (it) | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
US5607839A (en) * | 1993-07-22 | 1997-03-04 | Nippon Oil Company, Ltd. | Bacteria belonging to new genus process for production of carotenoids using same |
US6248361B1 (en) * | 1999-02-26 | 2001-06-19 | Integ, Ltd. | Water-soluble folic acid compositions |
ATE360651T1 (de) * | 2001-08-22 | 2007-05-15 | Supramol Parenteral Colloids | Hyperverzweigtes amylopektin zum einsatz in verfahren zur chirurgischen oder therapeutischen behandlung von säugern oder in diagnostizierverfahren, insbesondere zur verwendung als plasmavolumenexpander |
DE10237442B4 (de) * | 2002-08-16 | 2004-08-19 | Fresenius Kabi Deutschland Gmbh | Hochverzweigte, niedrig substituierte Stärkeprodukte |
US7446101B1 (en) | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
WO2006040335A1 (en) * | 2004-10-15 | 2006-04-20 | Danisco A/S | A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof |
US7781572B2 (en) | 2005-10-05 | 2010-08-24 | Nse Products, Inc. | Nanosized carotenoid cyclodextrin complexes |
WO2008080037A2 (en) * | 2006-12-21 | 2008-07-03 | Isp Investments Inc. | Carotenoids of enhanced bioavailability |
US8323615B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US9315715B2 (en) * | 2009-10-20 | 2016-04-19 | Nalco Company | Method of reducing the viscosity of hydrocarbons |
US8901092B2 (en) * | 2010-12-29 | 2014-12-02 | Surmodics, Inc. | Functionalized polysaccharides for active agent delivery |
DK2825565T3 (da) | 2012-03-15 | 2019-06-24 | Acraf | Glycogenbaserede kationiske polymere |
FR2989001B1 (fr) * | 2012-04-06 | 2017-07-21 | Centre Nat Rech Scient | Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine |
-
2014
- 2014-03-28 AR ARP140101413A patent/AR095937A1/es active IP Right Grant
- 2014-03-31 EA EA201591860A patent/EA032500B1/ru not_active IP Right Cessation
- 2014-03-31 GE GEAP201413971A patent/GEP201706742B/en unknown
- 2014-03-31 LT LTEP14713507.3T patent/LT2981557T/lt unknown
- 2014-03-31 EP EP14713507.3A patent/EP2981557B1/en active Active
- 2014-03-31 RS RS20200457A patent/RS60506B1/sr unknown
- 2014-03-31 UA UAA201509813A patent/UA119441C2/uk unknown
- 2014-03-31 KR KR1020157030658A patent/KR102113707B1/ko active IP Right Grant
- 2014-03-31 SI SI201431559T patent/SI2981557T1/sl unknown
- 2014-03-31 SG SG10201708099YA patent/SG10201708099YA/en unknown
- 2014-03-31 CN CN201480018127.4A patent/CN105143274B/zh not_active Expired - Fee Related
- 2014-03-31 WO PCT/EP2014/056451 patent/WO2014161815A1/en active Application Filing
- 2014-03-31 US US14/780,423 patent/US10662259B2/en active Active
- 2014-03-31 AU AU2014247145A patent/AU2014247145B2/en not_active Ceased
- 2014-03-31 CA CA2905273A patent/CA2905273A1/en not_active Abandoned
- 2014-03-31 MX MX2015013739A patent/MX369778B/es active IP Right Grant
- 2014-03-31 ES ES14713507T patent/ES2786900T3/es active Active
- 2014-03-31 DK DK14713507.3T patent/DK2981557T3/da active
- 2014-03-31 PT PT147135073T patent/PT2981557T/pt unknown
- 2014-03-31 PL PL14713507T patent/PL2981557T3/pl unknown
- 2014-03-31 SG SG11201507932RA patent/SG11201507932RA/en unknown
- 2014-03-31 HU HUE14713507A patent/HUE049561T2/hu unknown
- 2014-03-31 JP JP2016505785A patent/JP6312801B2/ja active Active
- 2014-03-31 BR BR112015024825A patent/BR112015024825A2/pt not_active Application Discontinuation
-
2015
- 2015-09-17 IL IL241690A patent/IL241690B/en active IP Right Grant
-
2016
- 2016-04-06 HK HK16103869.4A patent/HK1215955A1/zh unknown
-
2020
- 2020-04-29 HR HRP20200693TT patent/HRP20200693T1/hr unknown
- 2020-04-30 CY CY20201100399T patent/CY1122935T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017002053A2 (pt) | composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto | |
EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
BR112014029706A8 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
CL2015001756A1 (es) | Compuestos derivados de carbamoilpiridona policiclicos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion de vih en un humano que tiene o se encuentra en riesgo de tener la infeccion. | |
BR112015026830A8 (pt) | composto, composição farmacêutica, combinação, produto, uso de um composto, e, método para profilaxia ou tratamento de um estado de doença ou condição | |
BR112015027315A2 (pt) | melhorias nos ou relativas aos compostos orgânicos | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
BR112016001446A8 (pt) | composições terapêuticas, produto de combinação, uso in vitro de flecainida e flecainida | |
BR112015023523B8 (pt) | Composições farmacêuticas e recipiente de forma de dosagem única | |
BR112017002214A2 (pt) | composto de fórmula (i), composição farmacêutica e usos de um composto | |
BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112012012862A2 (pt) | composição farmacêutica compreendendo oligopeptídeos | |
BR112015030268A2 (pt) | composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição | |
BR112015010703A8 (pt) | Uso de uma composição farmacêutica e composição farmacêutica | |
BR112016010072A8 (pt) | conjugado, composição farmacêutica, usos do conjugado ou da composição farmacêutica, e de polissacarídeo de vi fragmentado, e, método para a fabricação de um conjugado | |
BR112017021190A2 (pt) | composição farmacêutica e o uso da mesma | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
BR112018007068A2 (pt) | derivados de quinoxalina e piridopirazina como inibidores de pi3kbeta | |
CY1122935T1 (el) | Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο | |
BR112015006692A2 (pt) | formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit. | |
BR112014029874A8 (pt) | composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica | |
BR112018007673A2 (pt) | ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos? | |
CL2016000397A1 (es) | Tratamiento contra el cáncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C08B 37/00 (2006.01), A61K 47/00 (2006.01), A61K 3 |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |